SISB INVESTMENT ADVISERS (UK) LTD

Institutional investor · Portfolio as of Q1 2019

SEC EDGAR SourceSEC Filings

Top Holdings1 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

Guardant Health, Inc.

27.9M$2.1B100.0%$40.56+89.11%
2 qtrssince 2018-Q4
Increased
70
$2.1B
AUM
1
Positions
Q1 2019
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q1'19
New0%Increased25%Decreased0%Exited75%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.0 quarters
<1Q0%1-4Q100%1-2Y0%2Y+0%

SB INVESTMENT ADVISERS (UK) LTD manages $2.1B across 1 positions as of Q1 2019. Top holdings: GH (100.0%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.

Q1 2019 Summary

Exited 1, increased 1. Top move: GH (INCREASED, conviction 70). Portfolio: $2.1B across 1 positions.

Top holdings by portfolio weight

Total AUM$2B
GH100.00%
NVDA0.00%

Portfolio allocation by GICS sector

Sectors1
Healthcare100.00%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used